These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 26650691

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
    Bell AJ, Fegen D, Ward M, Bank A.
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
    [Abstract] [Full Text] [Related]

  • 3. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications.
    Farley DC, Iqball S, Smith JC, Miskin JE, Kingsman SM, Mitrophanous KA.
    J Gene Med; 2007 May; 9(5):345-56. PubMed ID: 17366519
    [Abstract] [Full Text] [Related]

  • 4. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein.
    Kato S, Kuramochi M, Takasumi K, Kobayashi K, Inoue K, Takahara D, Hitoshi S, Ikenaka K, Shimada T, Takada M, Kobayashi K.
    Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473
    [Abstract] [Full Text] [Related]

  • 5. Optimized Lentiviral Transduction Protocols by Use of a Poloxamer Enhancer, Spinoculation, and scFv-Antibody Fusions to VSV-G.
    Anastasov N, Höfig I, Mall S, Krackhardt AM, Thirion C.
    Methods Mol Biol; 2016 Dec; 1448():49-61. PubMed ID: 27317172
    [Abstract] [Full Text] [Related]

  • 6. Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells.
    Trobridge GD, Wu RA, Hansen M, Ironside C, Watts KL, Olsen P, Beard BC, Kiem HP.
    Mol Ther; 2010 Apr; 18(4):725-33. PubMed ID: 19997089
    [Abstract] [Full Text] [Related]

  • 7. Altering Entry Site Preference of Lentiviral Vectors into Neuronal Cells by Pseudotyping with Envelope Glycoproteins.
    Kobayashi K, Kato S, Inoue K, Takada M, Kobayashi K.
    Methods Mol Biol; 2016 Apr; 1382():175-86. PubMed ID: 26611586
    [Abstract] [Full Text] [Related]

  • 8. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.
    Watson DJ, Kobinger GP, Passini MA, Wilson JM, Wolfe JH.
    Mol Ther; 2002 May; 5(5 Pt 1):528-37. PubMed ID: 11991743
    [Abstract] [Full Text] [Related]

  • 9. Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy.
    Gutierrez-Guerrero A, Cosset FL, Verhoeyen E.
    Viruses; 2020 Sep 11; 12(9):. PubMed ID: 32933033
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein.
    Höfig I, Barth S, Salomon M, Jagusch V, Atkinson MJ, Anastasov N, Thirion C.
    Biomaterials; 2014 Apr 11; 35(13):4204-12. PubMed ID: 24529898
    [Abstract] [Full Text] [Related]

  • 13. Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors.
    Hwang BY, Schaffer DV.
    Gene Ther; 2013 Aug 11; 20(8):807-15. PubMed ID: 23364315
    [Abstract] [Full Text] [Related]

  • 14. Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions.
    Kahl CA, Pollok K, Haneline LS, Cornetta K.
    Mol Ther; 2005 Mar 11; 11(3):470-82. PubMed ID: 15727944
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Dual-Pseudotyped Lentiviral Vector with VSV-G and Sendai Virus HN Enhances Infection Efficiency through the Synergistic Effect of the Envelope Proteins.
    Jargalsaikhan BE, Muto M, Been Y, Matsumoto S, Okamura E, Takahashi T, Narimichi Y, Kurebayashi Y, Takeuchi H, Shinohara T, Yamamoto R, Ema M.
    Viruses; 2024 May 23; 16(6):. PubMed ID: 38932120
    [Abstract] [Full Text] [Related]

  • 18. Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent.
    Janssens W, Chuah MK, Naldini L, Follenzi A, Collen D, Saint-Remy JM, VandenDriessche T.
    Hum Gene Ther; 2003 Feb 10; 14(3):263-76. PubMed ID: 12639306
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
    Chinnasamy N, Chinnasamy D, Toso JF, Lapointe R, Candotti F, Morgan RA, Hwu P.
    Hum Gene Ther; 2000 Sep 01; 11(13):1901-9. PubMed ID: 10986562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.